These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 18492963)

  • 21. Efficacy and safety of long-term ezetimibe/simvastatin treatment in patients with familial hypercholesterolemia.
    Katsiki N; Athyros VG; Karagiannis A; Mikhailidis DP
    Int Angiol; 2011 Jun; 30(3):295; author reply 296. PubMed ID: 21617615
    [No Abstract]   [Full Text] [Related]  

  • 22. Simvastatin with or without ezetimibe in familial hypercholesterolemia.
    Kaye T
    N Engl J Med; 2008 Jul; 359(5):531-2; author reply 532-3. PubMed ID: 18677800
    [No Abstract]   [Full Text] [Related]  

  • 23. Safe use of ezetimibe plus simvastatin in high-risk vascular patients (with chronic kidney disease and PAD).
    Aalbers J
    Cardiovasc J Afr; 2011; 22(4):227-8. PubMed ID: 21881698
    [No Abstract]   [Full Text] [Related]  

  • 24. Setting a new standard in achieving superior efficacy: ezetimibe + simvastatin.
    Farnier M
    Fundam Clin Pharmacol; 2007 Nov; 21 Suppl 2():27-8. PubMed ID: 18001317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simvastatin with or without ezetimibe in familial hypercholesterolemia.
    Blake JA
    N Engl J Med; 2008 Jul; 359(5):531; author reply 532-3. PubMed ID: 18677798
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniques.
    Ose L; Reyes R; Johnson-Levonas AO; Sapre A; Tribble DL; Musliner T
    Clin Ther; 2007 Nov; 29(11):2419-32. PubMed ID: 18158082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of effects of ezetimibe/simvastatin versus simvastatin versus atorvastatin in reducing C-reactive protein and low-density lipoprotein cholesterol levels.
    Pearson T; Ballantyne C; Sisk C; Shah A; Veltri E; Maccubbin D
    Am J Cardiol; 2007 Jun; 99(12):1706-1713. PubMed ID: 17560879
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does 'ENHANCE' diminish confidence in ezetimibe?
    Gandhi MJ
    J Assoc Physicians India; 2008 Sep; 56():665-6. PubMed ID: 19086351
    [No Abstract]   [Full Text] [Related]  

  • 29. Ezetimibe/simvastatin single tablet versus rosuvastatin in patients with hypercholesterolemia.
    Daskalopoulou SS; Mikhailidis DP
    Curr Med Res Opin; 2006 Oct; 22(10):2037-9. PubMed ID: 17022863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does ENHANCE diminish confidence in lowering LDL or in ezetimibe?
    Brown BG; Taylor AJ
    N Engl J Med; 2008 Apr; 358(14):1504-7. PubMed ID: 18376002
    [No Abstract]   [Full Text] [Related]  

  • 31. Lipid-lowering effects of ezetimibe and simvastatin in combination.
    Ijioma N; Robinson JG
    Expert Rev Cardiovasc Ther; 2011 Feb; 9(2):131-45. PubMed ID: 21453210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Uncertainty dogs Zetia and Vytorin.
    Harv Heart Lett; 2008 Nov; 19(3):7. PubMed ID: 19031588
    [No Abstract]   [Full Text] [Related]  

  • 33. Lipid-altering efficacy of the ezetimibe/simvastatin single tablet versus rosuvastatin in hypercholesterolemic patients.
    Catapano AL; Davidson MH; Ballantyne CM; Brady WE; Gazzara RA; Tomassini JE; Tershakovec AM
    Curr Med Res Opin; 2006 Oct; 22(10):2041-53. PubMed ID: 17022864
    [TBL] [Abstract][Full Text] [Related]  

  • 34. After the failure of ENHANCEd cholesterol lowering in familial hypercholesterolemia, SEAS of problems with ezetimibe.
    Mascitelli L; Ravnskov U; Pezzetta F; Goldstein MR
    Angiology; 2009; 60(1):127-8; author reply 129-30. PubMed ID: 19049996
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of combined ezetimibe and simvastatin therapy as compared with simvastatin alone in patients with type 2 diabetes: a prospective randomized double-blind clinical trial: comment on Ruggenenti et al.
    Sarigianni M; Katsiki N; Mikhailidis DP
    Diabetes Care; 2010 Oct; 33(10):e132; author reply e133. PubMed ID: 20876706
    [No Abstract]   [Full Text] [Related]  

  • 36. Increasing doses of simvastatin versus combined ezetimibe/simvastatin: effect on circulating endothelial progenitor cells.
    Pesaro AE; Serrano CV; Katz M; Marti L; Fernandes JL; Parra PR; Campos AH
    J Cardiovasc Pharmacol Ther; 2013 Sep; 18(5):447-52. PubMed ID: 23739650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of ezetimibe and low-dose simvastatin as primary treatment for dyslipidemia in peritoneal dialysis patients.
    Suzuki H; Inoue T; Watanabe Y; Kikuta T; Sato T; Tsuda M
    Adv Perit Dial; 2010; 26():53-7. PubMed ID: 21348380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The efficacy and safety of ezetimibe/simvastatin combination compared with intensified lipid-lowering treatment strategies in diabetic subjects with and without metabolic syndrome.
    Jimenez JG; Rosen JB; Pirags V; Massaad R; Hanson ME; Brudi P; Triscari J
    Diabetes Obes Metab; 2013 Jun; 15(6):513-22. PubMed ID: 23279632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of simvastatin-ezetimibe combination therapy on adipose tissue hormones and systemic inflammation in patients with isolated hypercholesterolemia.
    Krysiak R; Zmuda W; Okopien B
    Cardiovasc Ther; 2014 Apr; 32(2):40-6. PubMed ID: 24354929
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ezetimibe/simvastatin.
    Montecucco F; Quercioli A; Mach F
    Expert Opin Drug Saf; 2009 Nov; 8(6):715-25. PubMed ID: 19968571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.